Pharmadule Morimatsu is a global leader in modular pharmaceutical and biopharma manufacturing facilities. Pioneering modular delivery since 1986 and part of the Morimatsu Group since 2011, we design, fabricate, and deliver turnkey modular plants—combining process equipment, cleanrooms, and full facility solutions—for the life sciences and consumer products industries. Key benefits: Fixed-price certainty Flexible, scalable modules Rapid deployment worldwide (80% off-site fabrication) Reduced risk in time, cost, and quality From vaccine plants to biotech facilities, we provide fast, reliable, regulatory-compliant solutions delivered anywhere in the world. | We are a world leader in the delivery of innovative modular facilities and process equipment solutions for Life Science Industry. Originally founded in Sweden in 1986, Pharmadule was acquired in 2011 and is now part of the Morimatsu Industrial Group. This strong combination has allowed us to combine process modularization with modular facilities to deliver our clients complete turnkey solutions.
PharmaCircle
PharmaCircle will be showcasing our Partnership Explorer, a new analysis tool that helps business development professionals to identify external innovation and partnering opportunities. With PharmaCircle’s Partnership Explorer, you can easily explore and evaluate partnered and unpartnered pipeline programs and products by a host of filters including product name, molecule/API name, target name, company name, indication/disease area, molecule/API type, target type, mechanism type, phase, route, country/region, drug delivery category, and dosage form. PharmaCircle’s business intelligence and prospecting tools explore the business portfolios, capabilities, and transactions of more than 32,000 commercial and emerging stage life sciences companies and suppliers from around the world. PharmaCircle’s search and analysis tools include the Partnership Explorer; Terminated Programs Tracker; Strategic Deals Analyzer; Venture Capital & Funding Tracker; Pipeline & Products Intelligence with Formulation Details; Product Sales, Forecast & Unit Pricing Data; Company Profile PDF Reports; Disease Area PDF Reports; Epidemiology Explorer; Trial Landscape Explorer; Patent Exclusivity Tracker; Drug Delivery Technology Analyzer; CMOCRO Explorer; Prospector Business Development Map Tool; Spyglass Personalized Weekly Email News Brief. Since 2003, PharmaCircle has been providing commercial and emerging stage life sciences companies and suppliers the integrated data, powerful analysis tools and industry knowledge needed to solve complex, real-world challenges in product development and innovation. To see how we can help you, please visit our booth #1243 or website www.pharmacircle.com | PharmaCircle will be showcasing Partnership Explorer, a powerful analysis tool that helps business development professionals to identify external innovation and partnering opportunities, and enhancements to our Professional Subscription Service of business intelligence and prospecting solutions. With PharmaCircle’s Partnership Explorer, you can easily explore and evaluate more than 25,000 unpartnered programs and products by a host of filters, identify country/regional licensing opportunities, and track in-licensed and out-licensed products for each company. PharmaCircle’s Professional Subscription Service includes Pipeline & Products Intelligence; Company Profile Reports; Strategic Deals Analysis; Venture Capital & Funding Tracking; Product Sales, Forecast & Pricing; Epidemiology Explorer; Orphan Drug Analytics, Trial Landscape Explorer; Prospector Business Development Map Tool; CMOCRO Explorer; News & Insights; and Spyglass Personalized Weekly Email News Brief. PharmaCircle’s business intelligence and prospecting tools provide a comprehensive view of the business portfolios, capabilities, deals and funding transactions of more than 35,000 commercial and emerging stage life sciences companies and suppliers from around the world. Since 2003, PharmaCircle has been providing commercial and emerging stage life sciences companies and suppliers the integrated data, powerful analysis tools and industry knowledge needed to solve complex, real-world challenges in product development and innovation. To see how we can help you, please visit our booth #4155 or website www.pharmacircle.com. | PharmaCircle provides the curated data, powerful analysis tools and industry knowledge needed to solve complex, real-world challenges in drug product development and innovation. PharmaCircle’s search and evaluation tools identify unpartnered pipeline program opportunities and examine the pipeline/product portfolios and business transactions of commercial and emerging stage life sciences companies and their suppliers. PharmaCircle has been curating pharma pipeline intelligence, formulation/drug delivery information, and supply chain insights for more than 20 years. Our team of product developers and customer support personnel is comprised of scientists and business analysts from the life sciences industry. Many life sciences innovators and manufacturers rely on PharmaCircle’s curated content and expert analyses for mission-critical projects, and reference our data in conference presentations and published articles.
Phage Consultants
Phage Consultants is a company specializing in bacteriophage problems troubleshooting and prevention. It was founded in 2007 based on many years of experience in this field of its founder. Company, among other phage prevention- and troubleshooting-related activities, provides RCB, WCB and MCB testing for the presence of virulent phages and inducible prophages, also in strict anaerobes. Most probably, we have the greatest experience in this field on the whole global market. | PHAGE CONSULTANTS specializes in prevention and troubleshooting of phage contamination problems in various production and laboratory setups through a variety of services. We offer phage detection and identification services, facility audits and initial assessments, consultations, personnel training, advice on bioprocess optimization and SOP improvement, and new facility development. We also offer fast and reliable routine or as-required testing of incoming bacterial strains and cell banks for the presence of both lytic phages and prophages – a necessary tool in phage prevention. With these services, Phage Consultants can help you avoid phage contaminations and recover quickly from contaminations that have already occurred. | We are a company specializing in phage contamination troubleshooting and prevention with 18 years of experience on the market. We helped to solve over 200 cases of phage contamination in production facilities and research labs. Among the other activities, we provide RCB, WCB and MCB testing for the presence of virulent phages and inducible prophages, also in very unusual hosts like strict anaerobes. Such tests are very important in order to provide smooth production process and to avoid any problems with ready product. We also provide contract research in any field of phage use, which may be also the modification and fine tuning of microbiome. If our activity is anyhow interesting for you, I would be delighted to schedule a meeting with your representative.
PDR Design
For 30 years, PDR has been creating distinct, successful and award-winning products for innovative companies ranging from start-ups to blue chips across the world. Ranked as the #1 Design Agency in the UK for Medical Device design and in the top five in the US and Europe by the two leading global design ranking organisations. PDR has made hundreds of products covering everything from consumer goods to complex, life-critical medical devices from discovery and pipeline mapping through conception to successful market launch and beyond. Trusted by many of the world’s leading brands, PDR prides itself on repeatedly developing solutions that truly connect to users and challenge markets. Solutions which are consistently completed to budget, to target and on time. Services: • Medical Device Design • Human Factors and Usability Engineering • GUI Design • User Centred Design • Product Design • Industrial Design • Service Design • Consumer Insight Research • New Opportunity Identification and Execution
MediTox s. r. o.
MediTox s.r.o. is GLP-certified CRO dealing with preclinical R&D comprehensive preclinical and toxicological program for human/veterinary products (EMA, ICH/VICH, FDA), medical devices (ISO 10993), chemicals and agrochemicals (OECD TG), development of animal models of selected human diseases. Contract research activities are pointed to general toxicology and pharmacology (acute toxicity, long-term toxicity, immunogenicity, safety pharmacology, toxicokinetics, Proof-of-Concept), genetic toxicology (genotoxicity and mutagenicity in vitro and in vivo), biocompatibility of medical devices (local and systemic toxicity, implantation), safety assessment of vaccines, etc. The members of the toxicological team have experience with practically all species including NHP, dogs, ferrets, cats and pigs and various kinds of compounds and indications. Common and special ways of administration are available as well as GLP-compliant platform for bioanalyses, clinical pathology and histopathology. Undisputed advantages are an approval for handling GMO, experience with variety of compounds and therapeutic areas and in preclinical toxicology in non-rodent species, particularly in mini pig, ferret and dog models. C.I.R. accreditation was renewed for 2024 – 2026 OLAW (US National Institutes of Health) approval for 2020 – 2025 | MediTox s.r.o., a long established and fully GLP compliant, preclinical CRO, has been providing safety/efficacy evaluation for nearly 25 years: – non-clinical studies supporting phase I – III CT (exploratory & regulatory studies) – strong expertise in non-rodent toxicology – BEQ/BA/PK/TK studies – medical device (ISO 10993), small molecules, vaccines, biotech derived drugs, veterinary drugs, … (EMA/ICH/WICH/OECD/FDA) – influenza, chronic glaucoma, arthrosis, contact dermatitis models available – revision of study documentation (plan, data, report) MediTox s.r.o. provides specific services in multiples species, customized procedures, and tailored solutions. | x
LSK Global PS
LSK Global PS delivers a comprehensive, end-to-end clinical development model built on 26 years of industry experience, aligning strategy, operations, data, and regulatory functions to minimize delays, reduce risk, and ensure quality. Unified workflows across clinical operations, data management, and biostatistics enable efficient execution and timely submissions, while pharmacovigilance and medical writing are seamlessly incorporated to support submission-ready deliverables. Combined with academic and epidemiological expertise and extensive domestic and global trial experience, this approach strengthens regulatory readiness and supports successful clinical development in Korea.